A Delicious, Soy-Free Blend Supporting Muscle Growth, Recovery, and Overall WellnessOCALA, FL / ACCESSWIRE / October 3, 2024 ...

The company has achieved EBIDTA positive on a go-forward cash basis REDWOOD CITY, CA / ACCESSWIRE / October 3, 2024 / ...

Dr. Wilson brings over two decades of private practice experience to Modern Foot & Ankle, with expertise in sports medicine, ...

In the field of pharmaceutical marketing, artificial intelligence (AI) has already shown its potential to enable companies to ...

Dr. Mignone's expert ENT approach brings innovative VivAer® nasal relief to New Jersey residents.ROBBINSVILLE, NJ / ...

The Almac Group has today announced an £11m investment and the creation of over 100 new jobs to expand its global analytical ...

POTOMAC, MD / ACCESSWIRE / October 3, 2024 / IGC Pharma, Inc. (NYSE American:IGC) proudly announces that it won 2 awards in the PREPARE Challenge (Pioneering Research for Early Prediction of Alzheimer ...

New investors Pfizer Ventures and M Ventures co-led the financing, with participation from all existing investors including RA Capital, Samsara BioCapital and SV Health Investors Enara Bio’s EDAPT® ...

LAS VEGAS, NV / ACCESSWIRE / October 3, 2024 / CB Scientific, Inc. (OTC PINK:CBSC) ("CBSC" or the "Company"), a designer, manufacturer and distributor of non-invasive ambulatory cardiac monitoring ...

Announcing Acquisition of Advanced Gaming Technology Platform, Positive Progress on Legacy CBD Formulation, and Strengthened Balance SheetPALO ALTO, CA / ACCESSWIRE / October 3, 2024 / 180 Life ...

Oxford, England, 3rd October 2024 - MitoRx Therapeutics (MitoRx), a platform biotechnology company developing novel mitochondrial-targeted therapeutics in obesity-related disorders and myopathies ...

Syncona’s £63.5 million Series B commitment will be used by Resolution to progress the company and advance its lead candidate, RTX001 in end-stage liver diseaseRTX001 is expected to enter the clinic ...